Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Deficit) (Tables)

v3.24.1
Stockholders’ Equity (Deficit) (Tables)
12 Months Ended
Dec. 31, 2023
Stockholders’ Equity (Deficit) [Abstract]  
Schedule of Warrants Outstanding The following table summarizes our warrants outstanding as of the dates presented:
    Exercise
Price
    Expiration
Date
    As of
December 31,
2022
    Issued     Exercised     Expired     As of
December 31,
2023
 
2019 Public Warrants (1)   $ 4,600.00       6/19/2024       5,813,804         —          —         —       5,813,804  
2022 Unit Offering                                                        
Common Warrants (2)   $ 70.36       6/29/2027       43,478,261                         43,478,261  
Underwriter Warrants (2)   $ 70.36       6/29/2027       2,173,913                         2,173,913  
                      51,465,978                         51,465,978  
(1) The 2019 Public Warrants are exercisable for 14,535 shares of Common Stock at $4,600.00 per share or a ratio of 400 warrants for one share of Common Stock.
(2) The Common Warrants and Underwriter Warrants are exercisable for a combined amount of 114,130 shares of Common Stock at $70.36 per share or a ratio of 400 warrants for one share of Common Stock.